Stem Cells

HighQC™ Human IPSC From Fibroblasts With Niemann Pick Type C-Female Donor

  • For research use only

Cat No.

ABC-SC0021T

Product Type

Human iPSCs

Cell Type

Induced Pluripotent Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Niemann Pick Type C

Storage

Liquid Nitrogen

HighQC™ Human IPSC With Niemann Pick Type C Mutation provides a disease-specific stem cell model for NPC1-related pathogenesis and therapy development.

Product Image

Description

HighQC™ Human iPSC From Fibroblasts With Niemann Pick Type C-Female Donor is an induced pluripotent stem cell line reprogrammed from fibroblasts of an 8-year-old female patient diagnosed with Niemann-Pick Type C (NPC). The cell line was generated via episomal reprogramming using a proprietary mix of vectors, containing OCT4, SOX2, KLF4, p53 antisense, and EBNA-1. The cell line was validated for pluripotency based on classical colony morphology, alkaline phosphatase expression, and robust expression of key pluripotency markers including SSEA-4. The cell line is capable of differentiating into neural stem cells and functional neurons, making it especially suited for modeling neurodegenerative aspects of NPC. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.

Product Code

HighQC™ Human IPSC From Fibroblasts With Niemann Pick Type C-Female Donor, Human iPSC-Fib-NPC-F, hIPSC-Fib-NPC-F, Human Female Donor iPSC Niemann Pick Fibroblasts

Species

Human

Cat.No

ABC-SC0021T

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Induced Pluripotent Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Niemann Pick Type C

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Application

  • HighQC™ Human iPSC From Fibroblasts With Niemann Pick Type C-Female Donor serves as a physiologically relevant in vitro model for studying Niemann-Pick Type C disease’s mechanisms, including disrupted cholesterol transport and lysosomal dysfunction, and candidate compounds. Furthermore, the isogenic cell line enables mechanistic studies of Niemann-Pick Type C disease’s pathogenesis and validation of genetic correction strategies targeting the NPC1/NPC2 gene, supporting target identification and therapeutic development for this lysosomal storage disorder.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human IPSC From Fibroblasts With Niemann Pick Type C-Female Donor

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button